Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 8, 2024 $23.33 -1.86% $24.28 X 96.08% 0
Jan 8, 2024 $23.06 -2.98% $24.28 X 94.98% 0
thedean2010 thedean2010 Merchant
Jan 8, 2024 Bullish $24.28 V 1
Dec 18, 2023 $28.72 -2.68% $29.26 V 98.15% 1
Dec 18, 2023 $29.02 -1.67% $29.26 V 99.17% 3
Dec 18, 2023 Bullish $29.26 X 0
Sep 28, 2023 $17.35 +2.35% $16.86 X 97.11% 0
Sep 28, 2023 $17.20 +1.47% $16.86 X 97.99% 0
Sep 28, 2023 Bullish $16.86 X 0
Sep 5, 2023 $20.61 -2.05% $21.02 V 98.04% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE